Silmäasema Oyj Financial Statements Release 1 January –31 December 2019:
Excellent fourth quarter for Silmäasema – full-year adjusted EBITDA increased clearly year-on-year
Silmäasema Oyj
Stock Exchange Release - Financial Statements Release
This is a summary Silmäasema’s Financial Statements Release 2019. The complete report
is attached to this release and also available at https://company.silmaasema.fi/en/. Silmäasema does not arrange earnings call.
October–December 2019 in brief
- Net sales increased by 7.7% compared with October–December 2018, amounting to
EUR 34.8 million (32.4). The like-for-like net sales grew by 10.0%. - The adjusted EBITDA* increased by 66.9% and was
EUR 5.9 million (3.5), or 16.9% of net sales (10.9%). Without the impact of IFRS 16, the adjusted EBITDA would have been 11.9% of net sales (10.9%). - The adjusted operating result* increased by 29.9% to
EUR 2.6 million (2.0).
January–December 2019 in brief
- Net sales increased by 6.7% compared with January–December 2018, amounting to
EUR 131.1 million (122.9). The like-for-like net sales grew by 6.8%. - The adjusted EBITDA* increased by 82.7% and was
EUR 21.5 million (11.8), or 16.4% of net sales (9.6%). Without the impact of IFRS 16, the adjusted EBITDA would have been 10.8% (9.6%) of net sales. - The adjusted operating result* increased by 42.1% to
EUR 8.3 million (5.8). - Cash flows from operating activities* developed strongly and amounted to
EUR 18.5 million (13.1). - Net debt* was
EUR 46.1 million (28.0) at the end of the period. - The net debt to adjusted EBITDA ratio* was 2.1 (2.4) on
31 December 2019 . - Basic earnings per share improved to
EUR 0.28 (0.23).
The figures for 2018 are from the audited financial statements. The quarterly figures are unaudited. The figures in parentheses refer to the comparable period in 2018, and ‘comparison period’ refers to the corresponding period in the previous year, unless otherwise mentioned.
Proposed dividend
The Board of Directors proposes to the Annual General Meeting that no dividend be paid for the 2019 financial year.
Outlook for 2020
Silmäasema is not issuing an outlook for 2020, as it is impossible to assess the business impact of the coronavirus in sufficient detail at this stage.
* IFRS 16 affects the comparability of the reported figures
On
Key figures
EUR thousand, unless otherwise stated | 10–12/ 2019 | 10–12/ 2018 | Change, % | 1–12/ 2019 | 1–12/ 2018 | Change, % |
Net sales | 34,828 | 32,353 | 7.7% | 131,065 | 122,873 | 6.7% |
Comparable net sales growth, % | 10.0% | 0.0% | 6.8% | -1.6% | ||
EBITDA* | 5,356 | 3,131 | 71.1% | 20,268 | 11,443 | 77.1% |
Adjusted EBITDA*,** | 5,901 | 3,535 | 66.9% | 21,490 | 11,765 | 82.7% |
- Adjusted EBITDA*, % | 16.9% | 10.9% | 16.4% | 9.6% | ||
Operating result | 1,978 | 1,577 | 25.4% | 6,783 | 5,492 | 23.5% |
Adjusted operating result*,** | 2,573 | 1,981 | 29.9% | 8,303 | 5,844 | 42.1% |
- Adjusted operating result*, % | 7.4% | 6.1% | 6.3% | 4.8% | ||
Basic earnings per share, EUR* | 0.11 | 0.08 | 0.28 | 0.23 | ||
Net debt / adjusted EBITDA* | 2.1 | 2.4 | ||||
Investments – operational | 2,739 | 6,716 | -59.2% | |||
Investments – acquisitions | 1,588 | 1,775 | -10.5% | |||
Investments – total | 4,327 | 8,491 | -49.0% | |||
Number of locations, Silmäasema chain | 166 | 181 | -8.3% |
* The key figure is not comparable due to the adoption of the IFRS 16 standard at the beginning of 2019.
** Silmäasema presents both its adjusted EBITDA and adjusted operating result, which have been adjusted for significant extraordinary items. It is the company’s view that the adjusted EBITDA best illustrates the profitability development of its business operations.
Impact of IFRS 16 on the key figures
EUR thousand, unless otherwise stated | Reported 10–12/ 2019 | Without IFRS 16 10–12/ 2019 | IFRS 16 change | Reported 10–12/ 2018 | Reported 1–12/ 2019 | Without IFRS 16 1–12/ 2019 | IFRS 16 change | Reported 1–12/ 2018 |
EBITDA | 5,356 | 3,490 | 1,866 | 3,131 | 20,268 | 12,607 | 7,662 | 11,443 |
Adjusted EBITDA | 5,901 | 4,134 | 1,767 | 3,535 | 21,490 | 14,124 | 7,366 | 11,765 |
Adjusted EBITDA, % | 16.9% | 11.9% | 5.1% points | 10.9% | 16.4% | 10.8% | 5.6% points | 9.6% |
Operating result | 1,978 | 1,915 | 63 | 1,577 | 6,783 | 6,502 | 280 | 5,492 |
Adjusted operating result | 2,573 | 2,573 | 0 | 1,981 | 8,303 | 8,086 | 217 | 5,844 |
Profit before taxes | 1,444 | 1,508 | -64 | 1,199 | 4,883 | 5,244 | -361 | 4,123 |
Profit (loss) for the period | 1,579 | 1,630 | -51 | 1,190 | 3,959 | 4,247 | -289 | 3,254 |
Basic earnings per share, EUR | 0.11 | 0.11 | 0.00 | 0.08 | 0.28 | 0.30 | -0.02 | 0.23 |
Cash flow from operating activities | 18,540 | 11,678 | 6,862 | 13,092 | ||||
Net debt | 46,054 | 21,013 | 25,040 | 27,957 | ||||
Net debt / adjusted EBITDA (leverage) | 2.1 | 1.5 | 0.7 | 2.4 | ||||
Gearing, % | 103.1% | 46.8% | 56.4% points | 66.6% | ||||
Equity ratio | 38.4% | 49.0% | -10.6% points | 42.8% | ||||
Return on capital employed, % (ROCE) | 6.5% | 8.4% | -1.9% points | 6.9% | ||||
Return on equity, % (ROE) | 9.1% | 9.8% | -0.6% points | 8.1% |
CEO
“The fourth quarter and full-year result for 2019 is great. Fourth quarter was very good in terms of net sales and profitability as both
During these emergency conditions, we are planning our operations and personnel levels very closely. Our actions are guided by the thinking that once the restrictions regarding social contacts at some point will vanish, we will be in good position to serve customers even better and more versatile than before. The epidemic has already now boosted the creation of new kind of services and we are serving our customers more and more via telephone.
In 2019, a major change took place in Silmäasema’s ownership structure, and Silmäasema is becoming a wholly owned subsidiary of Coronaria through a redemption procedure. Coronaria is a Finnish company with a wide range of healthcare operations in the treatment of eye conditions in the public sector, for example, in addition to a holding in Medilaser. Coronaria provides a broad foundation for operational development at Silmäasema with a stronger focus on customers, as well as helping Silmäasema establish itself as the leading eye healthcare expert.
I want to thank our employees and partners for last year, and our customers for their trust. We will all face difficult times in the coming months. Despite all that, our goal for Silmäasema remains to be known among customers as the leading eye healthcare expert that offers a full range of eye healthcare services with effortless access. We want to be the first choice for customers, partners and employees.”
Board of Directors’ proposal for the distribution of profits
On
The Board will propose to the Annual General Meeting on
No significant changes have taken place in the company’s financial standing after the end of the financial year. The company’s liquidity is good. Due to its current ownership structure, the company sees no need for distributing a dividend.
Annual General Meeting
Silmäasema’s Annual General Meeting will be held on
SILMÄASEMA OYJ
Board of Directors
For further information, please contact:
Teppo Lindén, CEO, tel. +358 400 684 119, teppo.linden(a)silmaasema.fi
Silmäasema is a Finnish company, which offers all products and services for optical retail and eye healthcare nationwide. Silmäasema is the largest private eye clinic provider offering eye surgeries and the second largest optical retail chain in
Attachment
- EN - Silmäasema Oyj - Financial Statements Release 2019
© OMX, source